COMMUNIQUÉS West-GlobeNewswire

Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill
24/04/2026
Brooklyn biotech files 40-claim patent application covering a new active-ingredient combination for over-the-counter headache relief NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Plopii , a Brooklyn-based biotechnology [...]
ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026
24/04/2026
Healthcare products company unveils new brand identity and introduces Silkura, a revolutionary silicone-based ostomy pouch BERLIN, April 24, 2026 (GLOBE NEWSWIRE) -- ForLife Produktions- und Vertriebsgesellschaft für [...]
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
24/04/2026
Ruling preserves current contracted royalty rates and rejects Tesaro’s request for any royalty reduction Trial to adjudicate Anaptys’ contract claims and right to seek reversion of Jemperli against Tesaro/GSK is [...]
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
24/04/2026
Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders White Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- President [...]
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
24/04/2026
Webcast scheduled for Monday, April 27, 2026 at 8:00am ET. BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing [...]
Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026
24/04/2026
World’s first Phase 3 readout for an in vivo CRISPR gene editing candidate Company to host webcast to discuss data at 8:00 a.m. ET on April 27, 2026 CAMBRIDGE, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Intellia [...]
AEON Biopharma Sets Annual Shareholder Meeting
24/04/2026
- Annual Shareholder Meeting to be held at 10:00 am PT on June 17, 2026 - IRVINE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical [...]
Crescent Biopharma Announces Grants of Inducement Awards
24/04/2026
WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call
24/04/2026
MINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the quarter ended March 31 [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/04/2026
NOVATO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work
24/04/2026
A 2026 overview of Performance Lab supplements including Mind Lab Pro®, NutriGenesis® Multi, Omega-3, Sleep, Energy, and Vision — covering formulation standards, ingredient research context, third-party certifications, [...]
Metabo Drops 2026 | Launch "Tasteless Drop Effective Weight Loss Turns Any Coffee Into Boosted Metabolism Explained Fat Burning Supplement MetaboDrops
24/04/2026
Metabo Drops 2026 New tasteless liquid drops designed to support weight loss by turning any coffee into a metabolism-boosting drink for enhanced fat burning, energy support, and easier daily routine with consistent use [...]
Financière de Tubize - Dividend approval
24/04/2026
Dividend confirmation Regulated information - 24 April 2026 The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of a gross dividend of € [...]
Financière de Tubize - Approbation du dividende
24/04/2026
Approbation du dividende Information réglementée - 24 avril 2026 L’assemblée générale des actionnaires du 24 avril 2026 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31 décembre 2025, en ce [...]
KFSH Scales Genomic Medicine from Research to Clinical Decision-Making
24/04/2026
RIYADH, Saudi Arabia, April 24, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is advancing a clinically integrated model of genomic medicine, demonstrating how large-scale genetic [...]
Resolutions of the Annual General Meeting
24/04/2026
April 24, 2026 Announcement no. 10 Resolutions of the Annual General Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 24, 2026, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH: BIOPOR), an in vitro [...]
Acentra Health Chief AI Officer Sean Harrison Named to NVTC AI50
24/04/2026
Inaugural Award Highlights Executive and Company Dedication to AI Innovation in Northern Virginia Region MCLEAN, Va., April 24, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company [...]
A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform
24/04/2026
Pioneering Biosecurity for Genomic Data TOKYO, April 24, 2026 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare Co.) today announced GeneLock™, a new genomic security platform [...]
The Genius Song & The Brain Song Official 2026: 7-Second Brain Trick’ Genius Brainwave Music to Improve Focus and memory By Genius wave?
24/04/2026
The Genius Song Claims Evaluated Latest 2026 "7-Second Brain Trick" Read Report on Gamma Wave Audio Marketing, Consumer Report, Pricing, and What Consumers Should Verify New York City, April 24, 2026 (GLOBE NEWSWIRE [...]

Pages